Healthy valuation
19 February, 2016
Astorg Partners and its co-investor Goldman Sachs announced the acquisition of French pharmaceutical company HRA Pharma, specialist in women’s health and rare endocrine disorders. The transaction was led by Rothschild out of Paris.
Crescendo Partners was responsible for crafting the management presentation.